Novo Nordisk is reorganizing its research and early development unit in an effort to “future-proof the organization” and ...

NEW YORK, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...

Nashville Biosciences LLC (NashBio), a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center, and global DNA sequencing giant Illumina Inc.

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

HIGHLIGHTS •Aircore drilling to test priority targets expected to commence in late-March, weather dependent, at the Balla ...

Polen Capital, an investment management company, released its “Polen Global Growth Strategy” fourth-quarter 2024 investor ...

The use of AI in drug discovery and development has been recognised, explored, and implemented throughout the last decade, ...

By 2020, Chouinard’s discomfort with his ownership of the lucrative outdoor apparel brand was ramping up. While Patagonia has ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...

After 2 positive trials, low-dose colchicine’ got the FDA nod for CV reduction but then the CLEAR SYNERGY trial found no ...

Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...